BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30808702)

  • 1. HIV-1 Escape from Small-Molecule Antagonism of Vif.
    Sharkey M; Sharova N; Mohammed I; Huff SE; Kummetha IR; Singh G; Rana TM; Stevenson M
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
    Zuo T; Liu D; Lv W; Wang X; Wang J; Lv M; Huang W; Wu J; Zhang H; Jin H; Zhang L; Kong W; Yu X
    J Virol; 2012 May; 86(10):5497-507. PubMed ID: 22379088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
    Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
    Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.
    Ikeda T; Shimizu R; Nasser H; Carpenter MA; Cheng AZ; Brown WL; Sauter D; Harris RS
    mBio; 2023 Aug; 14(4):e0078223. PubMed ID: 37555667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
    Walker RC; Khan MA; Kao S; Goila-Gaur R; Miyagi E; Strebel K
    J Virol; 2010 May; 84(10):5201-11. PubMed ID: 20219919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
    Ao Z; Yu Z; Wang L; Zheng Y; Yao X
    PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
    Mandal D; Exline CM; Feng Z; Stoltzfus CM
    J Virol; 2009 Jun; 83(12):6067-78. PubMed ID: 19357165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.
    Britan-Rosich E; Nowarski R; Kotler M
    J Mol Biol; 2011 Jul; 410(5):1065-76. PubMed ID: 21763507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibition of HIV-1 Vif.
    Nathans R; Cao H; Sharova N; Ali A; Sharkey M; Stranska R; Stevenson M; Rana TM
    Nat Biotechnol; 2008 Oct; 26(10):1187-92. PubMed ID: 18806783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Wang X; York IA; Zheng YH
    J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
    Casartelli N; Guivel-Benhassine F; Bouziat R; Brandler S; Schwartz O; Moris A
    J Exp Med; 2010 Jan; 207(1):39-49. PubMed ID: 20038599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
    Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
    J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
    Pery E; Rajendran KS; Brazier AJ; Gabuzda D
    J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.
    Dang Y; Siew LM; Zheng YH
    J Biol Chem; 2008 May; 283(19):13124-31. PubMed ID: 18326044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.
    Green LA; Liu Y; He JJ
    J Biol Chem; 2009 May; 284(20):13363-13372. PubMed ID: 19324886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F.
    Yamashita T; Kamada K; Hatcho K; Adachi A; Nomaguchi M
    Microbes Infect; 2008; 10(10-11):1142-9. PubMed ID: 18603011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3G complexes decrease human immunodeficiency virus type 1 production.
    Martin KL; Johnson M; D'Aquila RT
    J Virol; 2011 Sep; 85(18):9314-26. PubMed ID: 21752914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.